Ads
related to: chemotherapy and cognitive impairment
Search results
Results From The WOW.Com Content Network
Post-chemotherapy cognitive impairment (PCCI) (also known in the scientific community as "CRCIs or Chemotherapy-Related Cognitive Impairments" and in lay terms as chemotherapy-induced cognitive dysfunction or impairment, chemo brain, or chemo fog) describes the cognitive impairment that can result from chemotherapy treatment.
Radiation-induced cognitive decline describes the possible correlation between radiation therapy and cognitive impairment. Radiation therapy is used mainly in the treatment of cancer. Radiation therapy can be used to cure, care or shrink tumors that are interfering with quality of life.
Some people receiving chemotherapy report fatigue or non-specific neurocognitive problems, such as an inability to concentrate; this is sometimes called post-chemotherapy cognitive impairment, referred to as "chemo brain" in popular and social media. [124]
Some clinicians and research groups in neuropsychology are developing programs to help treat the cognitive problems associated with childhood cancer. Treatment typically involves a program of cognitive rehabilitation which aims to help improve cognitive function either by restoring capacities that were impaired and/or helping the patient learn ways to compensate for the impairment(s).
The Princess of Wales did not go into detail about her own experience, it is common for people who undergo chemotherapy to describe experiencing some cognitive impairment after treatment ...
Cancer-related cognitive impairment may refer to : Post-chemotherapy cognitive impairment , also known as Chemotherapy-Related Cognitive Impairment Radiation-induced cognitive decline
Leqembi is approved for mild dementia and also a diagnosis known as mild cognitive impairment, where patients have more memory problems than others their age but can compensate and continue their ...
Clinically, diverse symptoms are observed, including motor deficits, headaches, cognitive impairment, cranial nerve involvement and neuropsychiatric changes. SCNSL in patients with ocular involvement may present as blurred vision and floaters. In older patients, asthenia, hearing impairment and urinary incontinence may be observed. [8]
Ad
related to: chemotherapy and cognitive impairment